Are thyroperoxidase (TPO) antibodies elevated in Hashimoto’s thyroiditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Thyroperoxidase Antibodies in Hashimoto's Thyroiditis

Yes, thyroperoxidase (TPO) antibodies are typically elevated in Hashimoto's thyroiditis and are a key diagnostic marker for this autoimmune thyroid disease. According to current guidelines, the presence of TPO antibodies is a hallmark feature of Hashimoto's thyroiditis and indicates an increased risk for developing hypothyroidism 1.

Diagnostic Value of TPO Antibodies

  • TPO antibodies are found in the majority of patients with Hashimoto's thyroiditis, with studies showing positivity in approximately 66% of cases even years before clinical diagnosis 2
  • TPO antibodies serve as a marker of autoimmune thyroid disease, particularly Hashimoto's thyroiditis 1
  • The NHANES III study specifically excluded individuals with detectable TPO antibodies when establishing reference ranges for thyroid function tests, recognizing their strong association with thyroid disease 3

Clinical Significance of TPO Antibodies

  • TPO antibodies are positively associated with:

    • Inflammation markers (TNF-α and IFN-γ) 4
    • Multiple extrathyroidal symptoms despite euthyroid status 4
    • Symptom burden including digestive, neuropsychiatric, and mucocutaneous manifestations 4
    • Decreased health-related quality of life 4
  • TPO antibody levels may remain elevated despite treatment:

    • While levothyroxine treatment often leads to a decline in TPO antibody levels (mean decrease of 70% after 5 years), they become negative in only about 16% of patients 5
    • This persistent elevation may explain why some patients continue to experience symptoms despite achieving biochemical euthyroidism 4

Relationship with Other Thyroid Antibodies

  • Hashimoto's thyroiditis is often characterized by the presence of both TPO antibodies and thyroglobulin (TG) antibodies 6
  • Some patients have bispecific antibodies (TGPO) that cross-react with both TPO and thyroglobulin 6
  • In Hashimoto's thyroiditis:
    • TPO antibodies are present in approximately 66% of cases
    • TG antibodies are present in approximately 53% of cases 2
    • These antibodies may be present years before clinical diagnosis 2

Clinical Application

  • Patients with positive TPO antibodies should have annual TSH monitoring, even if initially euthyroid, to detect progression to hypothyroidism 1
  • The presence of TPO antibodies in combination with elevated TSH confirms the diagnosis of autoimmune hypothyroidism (Hashimoto's thyroiditis) 1
  • Screening for other autoimmune disorders should be considered in patients with positive thyroid antibodies 1

Important Caveats

  • Not all patients with Hashimoto's thyroiditis have detectable TPO antibodies, so the absence of antibodies does not rule out the disease
  • TPO antibodies can occasionally be found in other autoimmune conditions and in some apparently healthy individuals 2
  • The relationship between antibody titers and disease severity is not always straightforward, though higher levels are generally associated with increased symptom burden 4, 7

In summary, TPO antibodies are a key diagnostic feature of Hashimoto's thyroiditis and their detection is an important component of the diagnostic workup for suspected autoimmune thyroid disease.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.